|
SMC6 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.192400E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.552660E-04 |
| Normal-vs-Stage2 |
4.979900E-02 |
| Normal-vs-Stage3 |
4.262300E-02 |
| Normal-vs-Stage4 |
1.784800E-01 |
| Stage1-vs-Stage2 |
8.510000E-01 |
| Stage1-vs-Stage3 |
2.494000E-01 |
| Stage1-vs-Stage4 |
2.183900E-02 |
| Stage2-vs-Stage3 |
4.362800E-01 |
| Stage2-vs-Stage4 |
2.023600E-01 |
| Stage3-vs-Stage4 |
4.159200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.393600E-04 |
| Normal-vs-AfricanAmerican |
2.922200E-01 |
| Normal-vs-Asian |
4.138700E-03 |
| Caucasian-vs-AfricanAmerican |
2.613400E-01 |
| Caucasian-vs-Asian |
3.241400E-01 |
| AfricanAmerican-vs-Asian |
1.382160E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.682750E-03 |
| Normal-vs-Female |
1.403690E-03 |
| Male-vs-Female |
5.956000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.188200E-01 |
| Normal-vs-Age(41-60Yrs) |
6.152300E-04 |
| Normal-vs-Age(61-80Yrs) |
2.897100E-03 |
| Normal-vs-Age(81-100Yrs) |
4.076400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.367200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.869800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.759200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.856000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.463600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.856600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.091820E-02 |
| Normal-vs-Grade 2 |
3.54080000000145E-05 |
| Normal-vs-Grade 3 |
2.579800E-02 |
| Normal-vs-Grade 4 |
3.972200E-01 |
| Grade 1-vs-Grade 2 |
4.366000E-01 |
| Grade 1-vs-Grade 3 |
2.347800E-02 |
| Grade 1-vs-Grade 4 |
9.924100E-03 |
| Grade 2-vs-Grade 3 |
1.008490E-02 |
| Grade 2-vs-Grade 4 |
3.302900E-03 |
| Grade 3-vs-Grade 4 |
3.192200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.98839999704981E-08 |
| Normal-vs-ccB subtype |
2.299600E-01 |
| ccA subtype-vs-ccB subtype |
3.50060000000596E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.159800E-03 |
| Normal-vs-N1 |
5.801000E-01 |
| N0-vs-N1 |
4.439000E-01 |
|
|
